Lymphoma presenting with spontaneous internal jugular and subclavian venous thrombosis and a large pleural effusion

A diffuse large B‐cell thyroid lymphoma presented as a compressive goiter in a young woman with no evidence of Hashimoto's thyroiditis

“…They are usually exudates resulting from four possible mechanisms: a tumor thoracic duct obstruction, direct pleural involvement of the lymphoma, an obstructed lymphatic return due to enlarged hilar or mediastinal lymph nodes, and infections. 22 The examination of the pleural fluid can be used to determine the mechanism of the pleural effusion. Pleural fluid cytology examination can also help to establish the diagnosis of DLBCL in case of a pleural involvement by lymphoma.…”

“…Although the frequency of pleural effusion is 20%-30% in lymphomas, the involvement of peritoneal and pericardial cavities is uncommon. 22 Pleural effusion due to lymphomas may adversely influence the patient's overall survival and it represents a predictor of disease relapse after chemotherapy. They are usually exudates resulting from four possible mechanisms: a tumor thoracic duct obstruction, direct pleural involvement of the lymphoma, an obstructed lymphatic return due to enlarged hilar or mediastinal lymph nodes, and infections.…”

“…Pleural effusion due to lymphomas may adversely influence the patient's overall survival and it represents a predictor of disease relapse after chemotherapy. They are usually exudates resulting from four possible mechanisms: a tumor thoracic duct obstruction, direct pleural involvement of the lymphoma, an obstructed lymphatic return due to enlarged hilar or mediastinal lymph nodes, and infections 22 . The examination of the pleural fluid can be used to determine the mechanism of the pleural effusion.…”

“…Serous effusions are a common complication of lymphomas. Although the frequency of pleural effusion is 20%–30% in lymphomas, the involvement of peritoneal and pericardial cavities is uncommon 22 . Pleural effusion due to lymphomas may adversely influence the patient's overall survival and it represents a predictor of disease relapse after chemotherapy.…”